Comparative analysis of T-cell costimulation and CD43 activation reveals novel signaling pathways and target genes

Ivan Mattioli1, Oliver Dittrich-Breiholz, Mark Livingstone

  • 1Department of Chemistry and Biochemistry, University of Bern, Freiestr. 3, 3012 Bern, Switzerland.

Blood
|July 29, 2004
PubMed

Insights

CD43 and T-cell receptor (TCR) signaling pathways in human T cells were compared. While both pathways share some signaling events, CD43 uniquely activates Jun N-terminal kinase (JNK) and distinct inflammatory gene expression.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • The CD43 lymphocyte surface receptor regulates T cell adhesion and activation.
  • CD43 functions and its signaling pathway overlap with the T-cell receptor (TCR) remain incompletely understood.

Purpose of the Study:

  • To systematically compare signaling events and target gene expression induced by CD43 versus T-cell costimulation.
  • To elucidate the distinct and shared signaling pathways utilized by CD43 and TCR.

Main Methods:

  • Primary human peripheral T cells were stimulated via CD43 ligation or T-cell costimulation.
  • Analysis included phosphorylation site identification (e.g., NF-kappaB p65), kinase activation (e.g., JNK), and gene expression profiling via microarrays.

Main Results:

  • Identified NF-kappaB p65 serine 468 as a novel phosphorylation site strongly induced by T-cell costimulation, but weakly by CD43.
  • Demonstrated CD43 as a novel activator of Jun N-terminal kinase (JNK).
  • Revealed overlapping yet distinct signaling pathways for CD43 and TCR, with unique inflammatory gene expression profiles for each.

Conclusions:

  • CD43 and TCR signaling pathways utilize both shared and distinct molecular mechanisms.
  • CD43 engagement uniquely activates JNK and influences specific inflammatory gene sets, differentiating its role from TCR costimulation.